A case of deep venous thrombosis associated with pegylated interferon α2b plus ribavirin treatment of chronic hepatitis C

Journal of Gastroenterology

Volumn 41, Issue 12, 2006, Pages 1231-1236

  Okuse, Chiaki ^a   Adachi, Kayo ^a   Katakura, Yoshiki ^a   Matsunaga, Kotaro ^a   Ishii, T Toshiya ^a   Matsumoto, Nobuyuki ^a   Yotsuyanagi, Hiroshi ^b   Iino, Shiro ^c   Suzuki, Michihiro ^a   Itoh, Fumio ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Kiyokawa Hospital   (Japan)

Author keywords

Chronic hepatitis C; Deep venous thrombosis; Pegylated interferon 2b plus ribavirin treatment

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA; WARFARIN; ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; ANTIVIRUS AGENT; PEGINTERFERON ALFA-2B; UNCLASSIFIED DRUG;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG WITHDRAWAL; ECHOGRAPHY; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LEG EDEMA; MALE; PAIN; PRIORITY JOURNAL; SYMPTOM; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; GENETICS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; VEIN THROMBOSIS;

AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RIBAVIRIN; RNA, VIRAL; VENOUS THROMBOSIS;

EID: 33947576457     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-006-1910-2     Document Type: Article

References (30)

1. HJ Alter LB Seeff 2000 Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome Semin Liver Dis 20 17-35 10895429 10.1055/s-2000-9505 1:STN:280:DC%2BD3M%2Fit12ltA%3D%3D
2. MP Manns JG McHutchison SC Gordon VK Rustgi M Shiffman R Reindollar 2001 Peginterferon α-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomized trial Lancet 358 958-65 11583749 10.1016/ S0140-6736(01)06102-5 1:CAS:528:DC%2BD3MXntF2qtb8%3D
3. MW Freid ML Shiffman KR Reddy C Smith G Marinos FL Goncales Jr 2002 Peginterferon α-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 975-82 10.1056/NEJMoa020047
4. JR Quesada M Talpaz A Rios R Kurzrock JU Gutterman 1986 Clinical toxicity of interferons in cancer patients: A review J Clin Oncol 4 234-43 2418169 1:STN:280:BimC3MvhsFI%3D
5. SW Schalm BE Hansen L Chemello A Bellobuono JT Brouwer O Weiland 1997 Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C J Hepatol 26 961-6 9186825 10.1016/ S0168-8278(97)80103-1 1:CAS:528:DyaK2sXjvF2hu7g%3D
6. López JA, Kearon C, Lee AY. Deep venous thrombosis. Hematology Am Soc Hematol Educ Program 2004;349-56
7. RD Rosenberg WC Aird 1999 Vascular bed specific hemostasis and hypercoagulable states N Engl J Med 340 1555-64 10332019 10.1056/ NEJM199905203402007 1:CAS:528:DyaK1MXjs1agtLg%3D
8. F Violi D Ferro S Basili M Artini G Valesini M Levrero 1995 Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis J Invest Med 43 550-4 1:STN:280:BymC1cfhtVc%3D
9. JM Pawlotsky MB Yahia C Andre MC Voisin L Intrator F Roudot-Thoraval 1994 Immunological disorders in C virus chronic active hepatitis: A prospective case-control study Hepatology 19 841-8 8138255 10.1016/ 0270-9139(94)90281-X 1:STN:280:ByuC1cnhs1Q%3D
10. J Matsuda N Saitoh M Gotoh K Gohchi M Tsukamoto S Syoji 1995 High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-α Am J Gastroenterol 90 1138-41 7611213 1:STN:280:ByqA3srlvFA%3D
11. FL Fimognari A De Santis C Piccheri R Moscatekki F Gigliotti A Vestri 2005 Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis J Lab Clin Med 146 238-43 16194685 10.1016/j.lab.2005.06.003 1:CAS:528:DC%2BD2MXhtVGrtrnK
12. P Sachdev 2004 Homocysteine and neuropsychiatric disorders Rev Bras Psiquiatr 26 49-55 10.1590/S1516-44462004000100013
13. P Stratta C Canavese M Dogliani A Thea G Degani L Mairone 1993 Hemolytic-uremic syndrome during recombinant alpha-interferon treatment for hairy cell leukemia Ren Fail 15 559-61 8210571 1:STN:280:ByuD38zivVw%3D
14. K Honda A Ando M Endo K Shimizu M Higashihara K Nitta 1997 Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myelocytic leukemia Am J Kidney Dis 30 123-30 9214412 1:STN:280:ByiA2Mjgs1U%3D
15. F Ravandi-Kashani J Cortes HM Kantarjian 1999 Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia. Coincidence or true side effect? Cancer 85 2583-8 10375106 10.1002/(SICI)1097-0142(19990615)85:12<2583::AID-CNCR14>3.0.CO;2-# 1:STN:280:DyaK1MzgtFKnsA%3D%3D
16. A Creutzig M Freund 1996 Severe Raynoud's syndrome associated with interferon therapy. A case history Angiology 47 185-7 8595014 1:STN:280:BymC2s3pvVI%3D
17. J Zuber F Martinez D Droz E Oksenhendler C Legendre 2002 For the Groupe d'Etude des Nephrologues d'Ile-de-France (Genif). Alpha-interferon-associated thrombotic microangiopathy. A clinicopathologic study of 8 patients and review of the literature Medicine 81 321-31 12169887 10.1097/00005792-200207000-00008 1:CAS:528:DC%2BD38Xmt1WhtLY%3D
18. L Lacotte V Thierry B Delwail F Guihot 1999 Thrombotic thrombocytopenic purpura during interferon alpha treatment for chronic myelogenous leukemia Acta Haematol 102 160-2 10.1159/000040993
19. A Nadir A Amin N Chalisa DH Thiel 2000 Retinal vein thrombosis associated with chronic hepatitis C: A case series and review of the literature J Viral Hepatitis 7 466-70 10.1046/j.1365-2893.2000.00245.x 1:STN:280:DC%2BD3M3it1yjsA%3D%3D
20. J Torrisi C Berg K Harter E Lvovsky K Yeung P Woolly 1986 Phase combined modality clinical trial of alpha-interferon and radiotherapy Int J Radiat Oncol Biol Phys 12 1453-6 3759573 1:STN:280:BiiD3cjot1A%3D
21. G Steineck H Strander BE Carbin E Borgstrom L Wallin U Achtnich 1990 Recombinant leukocyte interferon alpha-2a and medroxyprogesterone in advanced renal cell carcinoma. A randomized trial Acta Oncologica 29 155-62 2185803 1:STN:280:By%2BB2c7lvFE%3D
22. F Cnudde S Gharakhanian J Luboinski J Dry W Rozenbaum 1991 Cutaneous local necrosis following interferon injections Int J Dermatol 30 1472001907 1:STN:280:By6C287it10%3D
23. JM Durand N Quiles G Kaplanski J Soubeyrand 1993 Thrombosis and recombinant interferon-α Am J Med 95 115-6 8328488 10.1016/ 0002-9343(93)90242-H 1:STN:280:ByyA3MfovVE%3D
24. H Nishiwaki Y Ogura K Miyamoto N Hiroshiba M Hamada Y Honda 1997 Prednisolone, platelet-activating factor receptor antagonist, or superoxide dismutase reduced leukocyte entrapment induced by interferon alpha in retinal microcirculation Invest Ophthalmol Vis Sci 28 811-6
25. S Sugano T Suzuki M Watanabe K Ohe K Ishii T Okajima 1998 Retinal complications and plasma c5a levels during interferon alpha therapy for chronic hepatitis C Am J Gastroenterol 93 2441-4 9860406 10.1111/ j.1572-0241.1998.00701.x 1:CAS:528:DyaK1MXhs1GhsQ%3D%3D
26. P Fabris C Betterle NA Greggio R Zanchetta E Bosi MR Biasin 1998 Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis J Hepatol 28 514-7 9551692 10.1016/ S0168-8278(98)80328-0 1:CAS:528:DyaK1cXmvVWlu7o%3D
27. M Jadoul H Piessevaux A Ferrant JP Cosyns C van Ypersele de Strihou 1995 Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon-alpha 2b Nephrol Dial Transplant 10 111-3 7724004 1:STN:280:ByqB2c%2FovF0%3D
28. PG Canonico MD Kastello TM Cosgriff JC Donovan PE Ross CT Spears 1984 Hematological and bone marrow effects of ribavirin in rhesus monkeys Toxicol Appl Pharmacol 74 163-72 6740667 10.1016/0041-008X(84)90139-X 1:CAS:528:DyaL2cXkvVelsb8%3D
29. N Enomoto I Sakuma H Asahina M Kurosaki T Murakami C Yamamoto 1996 Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection N Engl J Med 334 77-81 8531962 10.1056/NEJM199601113340203 1:CAS:528:DyaK28XovVaktg%3D%3D
30. S Zeuzem M Buti P Ferenci Y Horsmans J Cianciara E Ibranyi 2006 Efficacy of 24 weeks treatment with peginterferon α-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia J Hepatol 44 97-103 16290907 10.1016/ j.jhep.2005.10.003 1:CAS:528:DC%2BD2MXht12ktLjL